-
公开(公告)号:US12116421B2
公开(公告)日:2024-10-15
申请号:US18021645
申请日:2021-09-02
Inventor: Charlotte A. E. Hauser , Maria Hountondji , Manola Moretti , Panagiotis Bilalis
CPC classification number: C07K7/06 , C12N5/0062 , C12N5/0601 , C12N2513/00 , C12N2533/50
Abstract: The present disclosure relates to Dopa containing ultrashort peptides capable of forming a gel, to a gel comprising a peptide in accordance with the present disclosure, and to a glue comprising a peptide in accordance with the present disclosure. Such gel is adhesive and is biocompatible. The peptides are suitable for building 3D structures, 3D printing, gluing as well as other applications.
-
公开(公告)号:US11994520B2
公开(公告)日:2024-05-28
申请号:US18038107
申请日:2021-11-22
Inventor: Charlotte A. E. Hauser , Panagiotis Bilalis , Dana Alhattab , Hepi Hari Susapto , Manola Moretti , Salwa Alshehri , Ali Aldoukhi , Hamed Albalawi , Hattan Boshah , Abdulelah Alrashoudi , Alexander Valle Perez , Rosario Perez Pedroza
IPC: C07K14/005 , C07K14/08 , G01N33/543 , G01N33/549 , G01N33/558 , G01N33/569
CPC classification number: G01N33/56983 , C07K14/005 , G01N33/54388 , G01N33/558 , C07K2319/00 , G01N2469/20
Abstract: The present disclosure relates a method of fabricating a literal flow immunoassay (LFIA) for the diagnosis of diseases, including COVID-19. The present disclosure further relates to a fusion-epitopes peptide that can be used in the LFIA test to improve sensitivity, specificity and accuracy of the test.
-
公开(公告)号:US20230408518A1
公开(公告)日:2023-12-21
申请号:US18038107
申请日:2021-11-22
Inventor: Charlotte A.E. Hauser , Panagiotis Bilalis , Dana Alhattab , Hepi Hari Susapto , Manola Moretti , Salwa Alshehri , Ali Aldoukhi , Hamed Albalawi , Hattan Boshah , Abdulelah Alrashoud , Alexander Valle Perez , Rosario Perez Pedroza
IPC: G01N33/569 , G01N33/543 , C07K14/005
CPC classification number: G01N33/56983 , G01N33/54388 , C07K14/005 , G01N2469/20 , C07K2319/00
Abstract: The present disclosure relates a method of fabricating a literal flow immunoassay (LFIA) for the diagnosis of diseases, including COVID-19. The present disclosure further relates to a fusion-epitopes peptide that can be used in the LFIA test to improve sensitivity, specificity and accuracy of the test.
-
公开(公告)号:US20230374069A1
公开(公告)日:2023-11-23
申请号:US18021645
申请日:2021-09-02
Inventor: Charlotte A.E. Hauser , Maria Hountondji , Manola Moretti , Panagiotis Bilalis
CPC classification number: C07K7/06 , C12N5/0062 , C12N5/0601 , C12N2533/50 , C12N2513/00
Abstract: The present disclosure relates to Dopa containing ultrashort peptides capable of forming a gel, to a gel comprising a peptide in accordance with the present disclosure, and to a glue comprising a peptide in accordance with the present disclosure. Such gel is adhesive and is biocompatible. The peptides are suitable for building 3D structures, 3D printing, gluing as well as other applications.
-
-
-